New hope for stomach cancer: first human trial of BDC-4182 begins
Disease control
Recruiting now
This study tests a new drug called BDC-4182 in people with advanced stomach or gastroesophageal cancer that has spread or cannot be removed by surgery. The goal is to see if the drug is safe and shrinks tumors. About 122 participants will receive the drug alone, and researchers w…
Phase: PHASE1, PHASE2 • Sponsor: Bolt Biotherapeutics, Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC